143 related articles for article (PubMed ID: 7506240)
1. Experience with a new intraurethral stent for high-risk patients with benign prostatic hypertrophy.
Fuse H; Okumura A; Sakamoto M; Katayama T
Int Urol Nephrol; 1993; 25(4):369-74. PubMed ID: 7506240
[TBL] [Abstract][Full Text] [Related]
2. [A self-retaining intraurethral device as an alternative to indwelling catheter and prostatectomy].
Nissenkorn I; Aronheim M; Sluzker D; Richter S
Harefuah; 1990 Nov; 119(9):254-6. PubMed ID: 1701751
[TBL] [Abstract][Full Text] [Related]
3. [Long-term results and indications of intraurethral stents in elderly patients with prostatic hypertrophy complaining of urinary retention].
Takeda M; Takahashi H; Tsutsui T; Go H; Hatano A; Sato S; Sasagawa T; Sakata Y; Hiraiwa M; Ando T
Hinyokika Kiyo; 1993 Nov; 39(11):1011-5. PubMed ID: 7505521
[TBL] [Abstract][Full Text] [Related]
4. [Experience of a double Malecot polyurethane intraurethral catheter in patients with dysuria].
Okumura A; Muraishi Y; Tsuritani S; Nagakawa O; Sakamoto M; Kazama T; Fuse H; Katayama T
Hinyokika Kiyo; 1994 May; 40(5):383-6. PubMed ID: 7517619
[TBL] [Abstract][Full Text] [Related]
5. Biodegradable braided poly(lactic-co-glycolic acid) urethral stent combined with dutasteride in the treatment of acute urinary retention due to benign prostatic enlargement: a pilot study.
Kotsar A; Isotalo T; Juuti H; Mikkonen J; Leppiniemi J; Hänninen V; Kellomäki M; Talja M; Tammela TL
BJU Int; 2009 Mar; 103(5):626-9. PubMed ID: 18990149
[TBL] [Abstract][Full Text] [Related]
6. [Urethral stent (Memotherm) for the treatment of benign prostatic hyperplasia].
Noda Y; Ujike T; Oka D; Takada S; Fujimoto N; Koide T
Hinyokika Kiyo; 2003 Nov; 49(11):645-7. PubMed ID: 14719451
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome of prostatic stent treatment for benign prostatic hyperplasia.
Chiou RK; Chen WS; Akbari A; Foley S; Lynch B; Taylor RJ
Urology; 1996 Oct; 48(4):589-93. PubMed ID: 8886065
[TBL] [Abstract][Full Text] [Related]
8. [The intraurethral catheter. A 3-year experience].
Nissenkorn I
J Urol (Paris); 1993; 99(6):321-3. PubMed ID: 7516379
[TBL] [Abstract][Full Text] [Related]
9. The management of acute urinary retention in France: a cross-sectional survey in 2618 men with benign prostatic hyperplasia.
Desgrandchamps F; De La Taille A; Doublet JD;
BJU Int; 2006 Apr; 97(4):727-33. PubMed ID: 16536763
[TBL] [Abstract][Full Text] [Related]
10. [Clinical study of intraurethral stent for patients with benign prostatic hypertrophy with 1-year follow up].
Ito T; Fujita K; Hori T; Sakagami H
Hinyokika Kiyo; 1994 Jul; 40(7):593-5. PubMed ID: 7521984
[TBL] [Abstract][Full Text] [Related]
11. Self-retaining intraurethral device for treatment of prostatic obstruction.
Cecchi M; Felipetto R; Viganò L; Minervini R; Fiorentini L
Acta Urol Belg; 1993 Dec; 61(4):17-20. PubMed ID: 7507632
[TBL] [Abstract][Full Text] [Related]
12. [Experience with polyurethane intraurethral stents in aged patients].
Tsujimoto Y; Yoshimoto T
Hinyokika Kiyo; 1993 Jun; 39(6):533-9. PubMed ID: 7687814
[TBL] [Abstract][Full Text] [Related]
13. Management of benign prostatic hyperplasia in high risk patients: long-term experience with the Memotherm stent.
Gesenberg A; Sintermann R
J Urol; 1998 Jul; 160(1):72-6. PubMed ID: 9628608
[TBL] [Abstract][Full Text] [Related]
14. Urethral stent (Angiomed-Memotherm) implantation in high-risk patients with urinary retention.
Uchikoba T; Horiuchi K; Satoh M; Oka F; Saitoh Y; Tsuboi N; Nishimura T
Hinyokika Kiyo; 2005 Apr; 51(4):235-9. PubMed ID: 15912781
[TBL] [Abstract][Full Text] [Related]
15. Transurethral ethanol injection for prostatic obstruction: an excellent treatment strategy for persistent urinary retention.
Mutaguchi K; Matsubara A; Kajiwara M; Hanada M; Mizoguchi H; Ohara S; Yasumoto H; Usui T
Urology; 2006 Aug; 68(2):307-11. PubMed ID: 16904442
[TBL] [Abstract][Full Text] [Related]
16. A randomized study to compare biodegradable self-reinforced polyglycolic acid spiral stents to suprapubic and indwelling catheters after visual laser ablation of the prostate.
Pétas A; Talja M; Tammela T; Taari K; Lehtoranta K; Välimaa T; Törmälä P
J Urol; 1997 Jan; 157(1):173-6. PubMed ID: 8976244
[TBL] [Abstract][Full Text] [Related]
17. The 12-year outcome analysis of an endourethral wallstent for treating benign prostatic hyperplasia.
Masood S; Djaladat H; Kouriefs C; Keen M; Palmer JH
BJU Int; 2004 Dec; 94(9):1271-4. PubMed ID: 15610103
[TBL] [Abstract][Full Text] [Related]
18. Self-retaining intraurethral stent: an alternative to long-term indwelling catheters or surgery in the treatment of prostatism.
Yachia D; Lask D; Rabinson S
AJR Am J Roentgenol; 1990 Jan; 154(1):111-3. PubMed ID: 1688478
[TBL] [Abstract][Full Text] [Related]
19. Placement of the urethral stent made of shape memory alloy in management of benign prostatic hypertrophy for debilitated patients.
Mori K; Okamoto S; Akimoto M
J Urol; 1995 Sep; 154(3):1065-8. PubMed ID: 7543599
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of high-energy transurethral microwave thermotherapy in alleviating medically refractory urinary retention due to benign prostatic hyperplasia.
Kellner DS; Armenakas NA; Brodherson M; Heyman J; Fracchia JA
Urology; 2004 Oct; 64(4):703-6. PubMed ID: 15491705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
